G. Funk (Vienna, Austria), F. Mihaltan (Bucharest, Romania), W. Pohl (Vienna, Austria)
Relationships between elevated cardiac troponin levels in COPD exacerbations and subsequent cardiac investigation and management
P. R. Vamadevan, A. W. Hitchings, D. Ahnood, T. S. Grewal, E. H. Baker (London, United Kingdom)
|  |
Comparison of multidimensional assessment systems with regard to risk prediction for exacerbations of COPD
T. Motegi, T. Ishii, K. Hattori, K. Kamio, K. Yamada, M. Kurahara, A. Gemma, K. Kida (Tokyo, Japan)
| |
Relation of red blood cell distribution width with long-term survival in acute exacerbation of chronic obstructive pulmonary disease
S. Altin, E. C. Seyhan, S. Sökücü, S. Tural, I. Tural, G. Günlüoglu (Istanbul, Turkey)
| |
Mathematical arterialisation for monitoring during exacerbation
U. M. Weinreich, B. Rychwicka-Kielek, B. Andersen, R. Bibi, L. Birket-Smith, S. R. Kristensen, S. E. Rees (Aalborg, Denmark)
| |
Do exacerbation outcomes in the POET-COPDÔ trial differ between regions?
M. P. M. H. Rutten-van Mölken, L. M. Fabbri, K. F. Rabe, H. Kögler, T. Glaab, H. Schmidt, K. M. Beeh, C. Vogelmeier (Rotterdam, Netherlands; Modena, Italy; Grosshansdorf, Ingelheim, Wiesbaden, Marburg, Germany)
| |
Effect of acute exacerbations on circulating thrombotic and fibrinolytic markers in COPD patients
R. Polosa, M. Malerba, A. Radaeli, J. Morjaria, R. Gullo, G. Di Maria (Catania, Brescia, Italy; Southampton, United Kingdom)
|  |
Predictors of mortality after hospitalisation for acute exacerbation of chronic obstructive pulmonary disease
Y. Wang, S. Humerfelt, K. Stavem, F. Dahl, T. Haugen (Lørenskog, Oslo, Norway)
| |
Development of an automated questionnaire for the early detection of COPD exacerbations (AQCE)
A. León, S. Astorga, M. Crespo, D. Sánchez, I. Failde, F. Crespo (Cadiz, Spain)
| |
Procalcitonin use in acute exacerbations of COPD
T. Medveczky, M. Jackson (Haywards Heath, United Kingdom)
| |
Characteristics of patients with chronic obstructive pulmonary disease (COPD) discharged from the emergency department – Improving the care pathway for acute exacerbations of COPD
S. Capocci, D. Turner, R. Pinate, M. Stern, L. Restrick (London, United Kingdom)
| |
Impact of pneumonia on mortality and length of stay in patients hospitalized with acute COPD exacerbations
S. L. Andreassen, E. D. Liaaen, N. Stenfors, A. H. Henriksen (Trondheim, Aalesund, Norway; Østersund, Umeå, Sweden)
| |
Infectional factors influences on cytomorphological picture of bronchial biopsies at COPD exacerbation
E. Bukreeva, G. Seitova, R. Pleshko (Tomsk, Russian Federation)
| |
Cognitive decline in stable and exacerbating COPD vs. controls
J. W. Dodd, R. A. Charlton, M. van den Broek, P. W. Jones (London, United Kingdom)
| |
Post discharge mortality in North Indian patients with exacerbation of COPD
H. Dar, U. Khan, P. Koul (Srinagar, India)
| |
CURB-65 and mortality in pneumonic and non-pneumonic exacerbations of COPD
J. Steer, G. J. Gibson, S. C. Bourke (North Shields, Newcastle-upon-Tyne, United Kingdom)
| |
Anemia in COPD patients with an exacerbation
M. Juarez Morales, J. De Miguel Díez, T. Gómez Garcia, J. García Angulo, J. Chancafe Morgan, G. Sánchez Muñoz, L. Puente Maestu (Madrid, Spain)
| |
Our experience of procalcitonin assay in identifying bacterial COPD exacerbations
C. Gough, P. Pillai, R. Mulla (Luton, United Kingdom)
| |
Profile of patients hospitalized with COPD acute exacerbation in respiratory department in Tunisia
H. Kamoun, I. Zendah, I. Khouaja, S. Sakka, A. Khattab, L. Bayahi, H. Ghedira (Ariana, Tunisia)
| |
Anemia in COPD patients in Spain: A systematic review
J. Diez-Manglano, J. Barquero-Romero (Zaragoza, Almendralejo, Spain)
| |
Interleukin-6, but not pentraxin 3, predicts adverse clinical outcomes on short-term prognosis of patients with incipient heart failure
P. Boschetto, B. Bottazzi, A. Fucili, A. Potena, L. Ballerin, M. Stendardo, S. Piva, A. Verduri, B. Beghé, A. Mantovani, L. Fabbri, R. Ferrari, C. Ceconi (Ferrara, Milano, Modena, Italy)
| |